RBC Capital Markets reiterated their positive stance on Alnylam Pharmaceuticals (NASDAQ:ALNY), maintaining an Outperform rating and a price target of $300.00. According to InvestingPro data, analyst ...

Tuesday saw RBC Capital Markets adjusting its expectations for several internet companies ahead of their earnings reports. Analysts at RBC provided insights into potential outcomes for Zillow Group ...

RBC Capital raised the firm’s price target on Securitas (SCTBF) to SEK 120 from SEK 105 and keeps an Underperform rating on the shares.Maximize ...

RBC Capital raised the firm’s price target on Volvo (VLVLY) to SEK 307 from SEK 294 and keeps a Sector Perform rating on the shares.Maximize ...

RBC Capital lowered the firm’s price target on PepsiCo (PEP) to $164 from $172 and keeps a Sector Perform rating on the ...

RBC Capital Markets analyst Bish Koziol made eight changes to his quantitatively driven top 40 list of stock picks. Maple ...

周一，RBC Capital Markets重申了对Palo Alto ...

Northern Trust Corporation announced today that Chief Financial Officer David Fox and Wealth Management President Jason Tyler will participate in the RBC 2025 Capital Markets Global Financial ...

周二，RBC Capital Markets重申了对Alnylam Pharmaceuticals (NASDAQ: ALNY ...

While Royal Bank focused on dealmaking in the U.S., its biggest domestic rival, TD, embraced retail banking — a 'cutthroat' ...